흑축이 3T3-L1 세포와 비만 유도 흰 쥐에 미치는 영향
Effects of Pharbitidis Semen on 3T3-L1 Cells and Obesity-induced Rats
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: This study was designed to evaluate the efficacy of Pharbitidis Semen (PS) on obesity using 3T3-L1 cells and high-fat-diet rats. Methods: After the administration of PS at a concentration of 0.125, 0.25, and 0.50 mg/ml in 3T3-L1 cells, the degree of differentiation of adipocytes was measured by Oil Red O staining. The experimental animals were divided into five groups in vivo. Normal group: diet-fed normal group (Normal), Control group (Control): high-fat-diet (HFD)-fed, Positive control group (PC): HFD+Contrave 200 mg/kg, PS_Low group: HFD+PS 250 mg/kg group, PS_High group: HFD+PS 500 mg/kg. Results: The total cholesterol, low density lipoprotein-cholesterol (LDL-cholesterol), and triglycerides (TG) content of the PS medication groups were significantly lower than those of the control group. In addition, high density lipoprotein cholesterol (HDL-cholesterol) tended to increase, and free fatty acid, total lipid, and phospholipid tended to decrease, but the decrease was not statistically significant. The administration of PS inhibited the differentiation of 3T3-L1 adipocytes, and a statistically significant difference was found in the group administered with 0.125 mg/ml. The mRNA expression of PPAR-γ and leptin, which are involved in the differentiation of adipocytes, was observed using reverse transcription polymerase chain reaction (RT-PCR). The expressions of PPAR-γ and leptin significantly decreased in comparison with the control and the positive control. Conclusions: PS can be applied clinically against obesity.
Abstract
Objectives: This study was designed to evaluate the efficacy of Pharbitidis Semen (PS) on obesity using 3T3-L1 cells and high-fat-diet rats. Methods: After the administration of PS at a concentration of 0.125, 0.25, and 0.50 mg/ml in 3T3-L1 cells, the degree of differentiation of adipocytes was measured by Oil Red O staining. The experimental animals were divided into five groups in vivo. Normal group: diet-fed normal group (Normal), Control group (Control): high-fat-diet (HFD)-fed, Positive control group (PC): HFD+Contrave 200 mg/kg, PS_Low group: HFD+PS 250 mg/kg group, PS_High group: HFD+PS 500 mg/kg. Results: The total cholesterol, low density lipoprotein-cholesterol (LDL-cholesterol), and triglycerides (TG) content of the PS medication groups were significantly lower than those of the control group. In addition, high density lipoprotein cholesterol (HDL-cholesterol) tended to increase, and free fatty acid, total lipid, and phospholipid tended to decrease, but the decrease was not statistically significant. The administration of PS inhibited the differentiation of 3T3-L1 adipocytes, and a statistically significant difference was found in the group administered with 0.125 mg/ml. The mRNA expression of PPAR-γ and leptin, which are involved in the differentiation of adipocytes, was observed using reverse transcription polymerase chain reaction (RT-PCR). The expressions of PPAR-γ and leptin significantly decreased in comparison with the control and the positive control. Conclusions: PS can be applied clinically against obesity.
참고문헌 (38)
- Guh DP, "The incidence of co-morbidities related to obesity and overweight : A systematic review and meta-analysis", BMC Public Health, 9(1), pp.88~ (2009)
- The Society of Korean Medicine Rehabilitation, "Korea rehabilitation medicine", pp.295~319 (2015), Koonja
- Kasper DL, "Harrison's principles of internal medicine", pp.559~570 (2010), MIP
- Committee of Clinical Practice Guideline of the Korean Soceity For The Study Of Obesity (KSSO), "Obesity Treatment Guideline 2018", ~ (2018)
- 박상아, "방풍통성산의 비만에 대한 약리학적 고찰 - 일본의 연구를 중심으로 -", 대한한의학 방제학회지, 22(2), pp.25~34 (2014), 대한한의학방제학회
- Choi WH, "The Effects Of Chekamuiyiin-tang On Biochemical And Histological Changes Of Rats Fed High Diet", Journal of Korean Oriental Medicine, 21(3), pp.31~39 (2000)
- 김혜주, "태음조위탕의 적용이 태음인 비만여대생의 신체조성, 혈청지질농도 및 혈중 항산화 효소에 미치는 효과", 사상체질의학회지, 23(3), pp.391~401 (2011), 사상체질의학회
- 이미정, "調胃升淸湯의 고지방식이 유도 비만 쥐에서 비만 및 고지혈증에 대한 효과 연구", 대한한의학회지, 32(4), pp.37~47 (2011), 대한한의학회
- 김소영, "차전초 잎의 물 추출물이 고지방식이로 비만이 유도된 C57BL", 6 생쥐에서 지질대사 단백질 발현에 미치는 영향, 2018, pp.33(3), 63~70[DOI]
- 곽진영, "赤小豆 外皮(Phaseolus angularis shell)의 고지방식이로 유도된 비만 동물모델에서 항비만, 항고지혈증 효과", 사상체질의학회지, 29(2), pp.136~153 (2017), 사상체질의학회[DOI]
- 마영훈, "桑葉이 비만 유발 생쥐의 인슐린 저항성 및 지방세포 염증에 미치는 영향", 대한한방내과학회지, 37(4), pp.609~623 (2016), 대한한방내과학회
- Co-textbook Compilation Committee of Nationwide College of Korean Medicine, "Bonchohak", pp.218~220 (2004), Yeonglimsa
- 김안근, "산화적 스트레스상태에서 B16F10 Murine Melanoma 세포의 항산화효소 활성에 대한 흑축추출물의 효과", 약 학 회 지, 48(1), pp.93~98 (2004), 대한약학회
- Kim KH, "Two new phenolic amides from the seeds of Pharbitis nil", Chem Pharm Bull, 58(11), pp.1532~1535 (2010)
- 고승규, "Anti-Cancer Effects and Apoptosis by Korean Medicinal Herbs", 동의생리병리학회지, 17(3), pp.819~825 (2003), 한의병리학회
- Ko SG, "Induction of apoptosis by Saussurea lappa and Pharbitis nil on AGS gastric cancer cells", Biological & pharmaceutical bulletin, 27(10), pp.1604~1610 (2004)
- 최현덕, "견우자의 생리활성 분석과 추출물로부터 항암 활성물질의 분리", 생명과학회지, 27(2), pp.225~232 (2017), 한국생명과학회
- Korean society for the study of obesity, "Clinical bariatrics", pp.19~20 (2001), Korea Medical Book Publishing Company
- Kim BS, "The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese Korean women", Journal of Ethnopharmacology, 152(3), pp.532~539 (2014)
- Yu Y, "Obese reversal by a chronic energy restricted diet leaves an increased Arc NPY", AgRP, but no alteration in POMC, Behavioural Brain Research, pp.2009, 205(1)[DOI]
- Koeppen-Schomerus G, "A genetic analysis of weight and overweight in 4-year-old twin pairs", Int J Obes Relat Metab Disord, 25(6), pp.838~844 (2001)
- Beom-Joon Lee, "The Anti-obesity Effects of Gambi-hwan Extract on Obese Rats Induced by High-fat Diet through the Expression of UCP-1 and PPARδ", 대한한의학회지, 28(4), pp.136~147 (2007), 대한한의학회
- Jiang C, "PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines", Nature, 391(6662), pp.82~86 (1998)
- Rosen ED, "PPARγ is required for the differentiation of adipose tissue in vivo and in vitro", Molecular cell, 4(4), pp.611~617 (1999)
- Shoelson SE, "Obesity, inflammation, and insulin resistance", Gastroenterology, 132(6), pp.2169~2180 (2007)
- Javor ED, "Long-term efficacy of leptin replacement in patients with generalized lipodystrophy", Diabetes, 54(7), pp.1994~2002 (2005)
- Kim DM, "Adiponectin &Vascular disease", Biowave, 8(11), pp.1~8 (2006)
- Nieto-Vazquez I, "Insulin resistance associated to obesity : the link TNF-alpha", Arch Physiol Biochem, 114(3), pp.183~194 (2008)
- 이재만, "죽엽이 알콜 투여로 유발된 흰쥐의 고지혈증과 간 손상의 예방에 미치는 영향", 대한본초학회지, 26(3), pp.31~36 (2011), 대한본초학회
- Preuss HG, "Efficacy of a novel calcium", potassium salt of(-)-hydroxycitric acid in weight control, 2005, pp.25(3), 133~144
- 김경윤, "양파와 한약재를 이용하여 개발된 한약 복합 처방 (HRO-1)이 비만 흰쥐에 미치는 영향", 동의생리병리학회지, 23(3), pp.562~566 (2009), 한의병리학회
- Rosen ED, "Transcriptional regulation of adipogenesis", Genes Dev, 14(11), pp.1293~1307 (2000)
- 강순아, "비만관련 한약혼합제제의 비만에 대한 효과", 대한본초학회지, 18(4), pp.59~64 (2003), 대한본초학회
- Fajas L, "Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1", sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism, 1999, pp.19(8), 5495~5503
- Committee of Clinical Practice Guideline of the Korean Society of Lipid and Atherosclerosis (KSoLA), "Korean Guidelines for the Management of Dyslipidemia", pp.31~45 (2018), Academya